Delek Us控股 DK 深滬

等待開盤 01-13 09:30:00 美东时间

29.51

-1.100

-3.59%

華盛通

立即下載

最高30.55
今開30.26
成交量 119.40万股
最低 29.25
昨收 30.61
總市值 17.70亿
52周最高 43.245
市盈率 ^靜 --
換手率 1.99%
52周最低 10.26
委比 60.00%
總股本 5999.17万
歷史最高 55.43
量比 0.85
振幅 4.25%
歷史最低 0.505
每手 1
風險率 8.69%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元

01-09 20:22
Piper Sandler Maintains Neutral on Delek US Hldgs, Lowers Price Target to $40

Piper Sandler analyst Ryan Todd maintains Delek US Hldgs (NYSE:DK) with a Neutral and lowers the price target from $47 to $40.

01-08 22:59
Top 3 Energy Stocks That May Explode This Month

The most oversold stocks in the energy sector presents an opportunity to buy in...

01-02 19:05
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价

今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元

2025-12-15 15:30
Mizuho Maintains Outperform on Delek US Hldgs, Raises Price Target to $51

Mizuho analyst Nitin Kumar maintains Delek US Hldgs (NYSE:DK) with a Outperform and raises the price target from $45 to $51.

2025-12-12 20:49
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价

今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元

2025-11-19 11:01
美股大行评级 | 花旗上调Bilibili目标价升至27美元；摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级

花旗上调Bilibili目标价升至27美元；摩根士丹利上调英伟达目标价升至220美元；Ardent Health、Stubhub遭多家大行下调评级>>

2025-11-17 10:49
Piper Sandler Maintains Neutral on Delek US Hldgs, Raises Price Target to $47

Piper Sandler analyst Ryan Todd maintains Delek US Hldgs (NYSE:DK) with a Neutral and raises the price target from $39 to $47.

2025-11-14 23:42
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元

今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元

2025-11-12 11:43
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价

今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元

2025-11-11 10:49

派息除權日	每股總股息	派息日期
2025-11-10	0.25	2025-11-17
2025-08-11	0.25	2025-08-18
2025-05-12	0.25	2025-05-19
2025-03-03	0.25	2025-03-10
2024-11-12	0.25	2024-11-18
2024-08-12	0.25	2024-08-19
2024-05-16	0.25	2024-05-24
2024-02-29	0.25	2024-03-08
2023-11-10	0.24	2023-11-20
2023-08-11	0.23	2023-08-21
2023-05-12	0.23	2023-05-22
2023-03-09	0.22	2023-03-17
2022-11-17	0.21	2022-12-02
2022-08-19	0.20	2022-09-06
2022-07-11	0.20	2022-07-20
2020-08-18	0.31	2020-09-03
2020-05-19	0.31	2020-06-03
2020-03-09	0.31	2020-03-24
2019-11-15	0.30	2019-12-02
2019-08-16	0.29	2019-09-03
2019-05-17	0.28	2019-06-03
2019-03-04	0.27	2019-03-19
2018-11-19	0.26	2018-12-04
2018-08-20	0.25	2018-09-04
2018-05-18	0.25	2018-06-04
2018-03-09	0.20	2018-03-26
2017-11-21	0.15	2017-12-15
2017-08-21	0.15	2017-09-13
2017-05-19	0.15	2017-06-02
2017-03-13	0.15	2017-03-29
2016-11-18	0.15	2016-12-13
2016-08-19	0.15	2016-09-13
2016-05-20	0.15	2016-06-14
2016-03-11	0.15	2016-03-29
2015-11-20	0.15	2015-12-15
2015-08-21	0.15	2015-09-15
2015-05-21	0.15	2015-06-16
2015-03-06	0.15	2015-03-24
2015-01-02	0.10	2015-01-27
2014-11-21	0.15	2014-12-16
2014-10-07	0.10	2014-10-30
2014-08-22	0.15	2014-09-16
2014-06-24	0.10	2014-07-17
2014-05-22	0.15	2014-06-17
2014-04-01	0.10	2014-04-24
2014-03-07	0.15	2014-03-25
2014-01-03	0.10	2014-01-28
2013-11-22	0.15	2013-12-17
2013-10-04	0.10	2013-10-29
2013-08-23	0.15	2013-09-17
2013-07-05	0.10	2013-07-30
2013-05-23	0.15	2013-06-18
2013-03-22	0.10	2013-04-16
2013-02-22	0.10	2013-03-19
2013-01-04	0.10	2013-01-29
2012-11-23	0.10	2012-12-18
2012-10-12	0.10	2012-10-30
2012-08-17	0.04	2012-09-18
2012-07-13	0.10	2012-07-31
2012-05-18	0.04	2012-06-19
2012-04-03	0.09	2012-04-19
2012-02-24	0.04	2012-03-20
2011-11-18	0.22	2011-12-20
2011-08-22	0.04	2011-09-21
2011-05-20	0.04	2011-06-21
2011-02-25	0.04	2011-03-22
2010-11-16	0.04	2010-12-14
2010-08-20	0.04	2010-09-21
2010-05-21	0.04	2010-06-22
2010-02-23	0.04	2010-03-18
2009-11-20	0.04	2009-12-15
2009-08-24	0.04	2009-09-16
2009-05-22	0.04	2009-06-17
2009-02-13	0.04	2009-03-11
2008-11-21	0.04	2008-12-16
2008-08-25	0.04	2008-09-17
2008-05-15	0.04	2008-06-09
2008-02-15	0.04	2008-03-07
2007-11-01	0.24	2007-11-19
2007-08-16	0.04	2007-09-07
2007-04-12	0.24	2007-04-30
2007-02-15	0.04	2007-03-07
2006-11-16	0.04	2006-12-07

公司名稱	Delek Us控股
行業分類	油气精炼销售
業務描述	Delek US Holdings, Inc. engages in petroleum refining, and the transportation, storage, and wholesale distribution of crude oil. It operates through the following segments: Refining and Logistics, The Refining segment processes crude oil and other purchased feedstocks for the manufacture of transportation motor fuels, including gasoline, diesel fuel and aviation fuel, asphalt, and other petroleum-based products. The Logistics segment gathers, transports, and stores crude oil and markets, distributes, transports, and stores refined products. The company was founded in 2001 and is headquartered in Brentwood, TN.

Delek Us控股 DK 深 滬

29.51

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Delek Us控股 DK 深滬